![Tatsuzo Ishigami](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Tatsuzo Ishigami
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Watervein Partners KK
![]() Watervein Partners KK Investment ManagersFinance Watervein Partners KK (Watervein Partners) is an independent venture capital firm headquartered in Tokyo, Japan. The firm was founded in 2002 by Kuroishi Masafumi.
3
| Private Company | Investment Managers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Tatsuzo Ishigami via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
Tokyo Institute of Technology | College/University | Graduate Degree | |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
CellGenTech, Inc.
![]() CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan. | Pharmaceuticals: Major | Director/Board Member | |
KinoPharma, Inc.
![]() KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Japan | 5 |
Verenigde Staten | 2 |
Sectoraal
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Operationeel
Private Equity Investor | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sterkste connecties
Insiders | |
---|---|
Tetsuya Mishima | 5 |
Masafumi Kuroishi | 2 |
Masanori Ishikawa | 1 |
- Beurs
- Insiders
- Tatsuzo Ishigami
- Bedrijfsconnecties